As the global economy mends, the 2021 growth of Pneumococcal Vaccine Polyvalent will have significant change from previous year. According to our researcher latest study, the global Pneumococcal Vaccine Polyvalent market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pneumococcal Vaccine Polyvalent market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Pneumococcal Vaccine Polyvalent market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pneumococcal Vaccine Polyvalent market, reaching US$ million by the year 2028. As for the Europe Pneumococcal Vaccine Polyvalent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pneumococcal Vaccine Polyvalent players cover Merck & Co., Pfizer, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccine Polyvalent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Prevnar 13

Pneumovax23

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

18 Years and Younger

19 To 64 Years Old

65 Years and Older

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck & Co.

Pfizer